Dihydrofolate reductase transcript level is not suitable for methotrexate-resistance prediction in choriocarcinoma cell line

International Journal of Gynecological Cancer

Volumn 20, Issue 7, 2010, Pages 1-

  Han, Bing ^a   Xiang, Yang ^a   Wang, Yun ^a   Wang, Zheng ^a   Zhang, Hao ^a   Huang, Shangzhi ^a  

^a PEKING UNION MEDICAL COLLEGE   (China)

Author keywords

Chemoresistance; Choriocarcinoma; Dihydrofolate reductase; JeG 3 cell line; MTX

Indexed keywords

ANTINEOPLASTIC ANTIMETABOLITE; DIHYDROFOLATE REDUCTASE; MESSENGER RNA; METHOTREXATE;

ARTICLE; CHORIOCARCINOMA; DRUG RESISTANCE; ENZYMOLOGY; FEMALE; GENETICS; HUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL CULTURE; UTERUS CANCER;

ANTIMETABOLITES, ANTINEOPLASTIC; CHORIOCARCINOMA; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; METHOTREXATE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TETRAHYDROFOLATE DEHYDROGENASE; TUMOR CELLS, CULTURED; UTERINE NEOPLASMS;

EID: 79960689312     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1111/IGC.0b013e3181f05128     Document Type: Article

References (0)